Literature DB >> 8583847

Quantitative study of vestibulotoxicity induced by gentamicin or cisplatin in the guinea pig.

M Nakayama1, L C Riggs, G J Matz.   

Abstract

Although aminoglycoside vestibulotoxicity is well established, the question of cisplatin vestibulotoxicity is controversial. The goals of this study were 1. to determine whether cisplatin induces vestibulotoxicity as measured histologically, and 2. to compare the vestibulotoxicity between gentamicin and cisplatin. Guinea pigs' vestibular end-organ hair bundles in control, gentamicin, and cisplatin groups were compared. In the lateral cristae of the cisplatin group, hair bundles decreased 21% on the central apex portion. In the gentamicin group, a slight decrease (17%) of hair bundles on the striola from the utricular maculae was observed, as was severe damage on the entire cristae, especially on the central apex (70%). These results indicate that gentamicin and cisplatin may not influence vestibular function of the otolithic membrane. However, gentamicin may severely damage and cisplatin may slightly damage the crista ampullaris hair bundles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8583847     DOI: 10.1097/00005537-199602000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Cisplatin exposure damages resident stem cells of the mammalian inner ear.

Authors:  Eric L Slattery; Kazuo Oshima; Stefan Heller; Mark E Warchol
Journal:  Dev Dyn       Date:  2014-06-25       Impact factor: 3.780

2.  Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review.

Authors:  Pattarawadee Prayuenyong; John A Taylor; Stephanie E Pearson; Rachel Gomez; Poulam M Patel; Deborah A Hall; Anand V Kasbekar; David M Baguley
Journal:  Front Oncol       Date:  2018-09-25       Impact factor: 6.244

Review 3.  Preferential Cochleotoxicity of Cisplatin.

Authors:  Pattarawadee Prayuenyong; David M Baguley; Corné J Kros; Peter S Steyger
Journal:  Front Neurosci       Date:  2021-07-26       Impact factor: 4.677

4.  Persistence of the otoprotective effect: how long does otoprotection against amikacin lasts?

Authors:  Andreia Ardevino de Oliveira; Matheus de Souza Campos; Adriana de Andrade Batista Murashima; Maria Rossato; Miguel Angelo Hyppolito; José Antônio Apparecido de Oliveira
Journal:  Braz J Otorhinolaryngol       Date:  2012-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.